BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24927150)

  • 1. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
    Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA
    Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products.
    Mudit M; Khanfar M; Muralidharan A; Thomas S; Shah GV; van Soest RW; El Sayed KA
    Bioorg Med Chem; 2009 Feb; 17(4):1731-8. PubMed ID: 19195897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
    Foudah AI; Sallam AA; Akl MR; El Sayed KA
    Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, optimization, and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk/Paxillin/Rac1 axis.
    Elsayed HE; Akl MR; Ebrahim HY; Sallam AA; Haggag EG; Kamal AM; El Sayed KA
    Chem Biol Drug Des; 2015 Feb; 85(2):231-43. PubMed ID: 24954090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling.
    Akl MR; Foudah AI; Ebrahim HY; Meyer SA; El Sayed KA
    Mar Drugs; 2014 Apr; 12(4):2282-304. PubMed ID: 24736807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
    Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
    Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
    Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
    Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for evaluation of structural and biological properties of antiinvasive natural products.
    Mudit M; Khanfar M; Shah GV; Sayed KA
    Methods Mol Biol; 2011; 716():55-71. PubMed ID: 21318900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitacin B suppresses metastasis mediated by reactive oxygen species (ROS) via focal adhesion kinase (FAK) in breast cancer MDA-MB-231 cells.
    Luo WW; Zhao WW; Lu JJ; Wang YT; Chen XP
    Chin J Nat Med; 2018 Jan; 16(1):10-19. PubMed ID: 29425586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semisynthetic oleanane triterpenoids inhibit migration and invasion of human breast cancer cells through downregulated expression of the ITGB1/PTK2/PXN pathway.
    Lisiak N; Paszel-Jaworska A; Totoń E; Rubiś B; Pakuła M; Bednarczyk-Cwynar B; Zaprutko L; Rybczyńska M
    Chem Biol Interact; 2017 Apr; 268():136-147. PubMed ID: 28322779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
    Yadav B; Taurin S; Larsen L; Rosengren RJ
    Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
    Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
    Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway.
    Pan X; Han H; Wang L; Yang L; Li R; Li Z; Liu J; Zhao Q; Qian M; Liu M; Du B
    Cancer Lett; 2011 Dec; 313(2):181-91. PubMed ID: 21959111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
    Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
    Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
    Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
    Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway.
    Du T; Qu Y; Li J; Li H; Su L; Zhou Q; Yan M; Li C; Zhu Z; Liu B
    Mol Cancer; 2014 May; 13():100. PubMed ID: 24885567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A therapeutic trial of human melanomas with combined small interfering RNAs targeting adaptor molecules p130Cas and paxillin activated under expression of ganglioside GD3.
    Makino Y; Hamamura K; Takei Y; Bhuiyan RH; Ohkawa Y; Ohmi Y; Nakashima H; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2016 Aug; 1860(8):1753-63. PubMed ID: 27068854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.